key: cord-0718860-03kj3e06
authors: Denina, Marco; Pellegrino, Francesco; Morotti, Francesco; Coppo, Paola; Bonsignori, Ilaria Maria; Garazzino, Silvia; Ravanini, Paolo; Avolio, Maria; Cavallo, Rossana; Bertolotti, Luigi; Felici, Enrico; Acucella, Gabriela; Montin, Davide; Rabbone, Ivana; Licciardi, Francesco
title: All that glisters is not COVID: low prevalence of seroconversion against SARS-CoV-2 in a pediatric cohort of patients with Chilblain-like lesions
date: 2020-08-08
journal: J Am Acad Dermatol
DOI: 10.1016/j.jaad.2020.08.021
sha: 1988d7718fab0f6bb5aec14b34b6b34863a9515a
doc_id: 718860
cord_uid: 03kj3e06

nan

J o u r n a l P r e -p r o o f On January 7th, 2020, a novel coronavirus, SARS-CoV-2, was isolated in a patient affected by interstitial 39 pneumonia. As SARS-CoV2 infection spread worldwide, an increasing number of authors reported 40 chilblains-like lesions (CLL) as possible manifestations of SARS-CoV-2 infection. 1,2 41 To test this hypothesis, we performed serologic and stool/rectal PCR tests in a cohort of children who 42 developed CLL during the SARS-CoV-2 outbreak in Italy, between March 8th and April 30th, 2020. 43 Enrolment criteria are described in Supplemental Material 3 . 44

During the enrolment period 35 cases of CLL were eligible for the study, 24 patients agreed to serologic 45 testing (68.6%). 46

All patients were Caucasian, mean age was 13 years old (6-17), female to male ratio 2:1. Twenty-two 47 patients presented with chilblains at toes (Figure 1 ), in 2 lesions were located on the heels; 6 patients 48 developed blistering lesions; 83% of lesions lasted more than 14 days, 8% lasted less than one week. 49

Two patients had known contact with SARS-CoV-2-positive individuals, defined by positive nasal swab. 50

Seven more patients had close contact with someone who presented symptoms that might be SARS-51

CoV-2 related such as asthenia, loss of smell (anosmia), cough, and prolonged fever. In 25% of cases, at 52 least one parent was a health worker. Further details are available in Supplemental Results 3 . 53

Chemiluminescence assay (LIAISON® SARS-CoV-2 IgG, Diasorin) was performed in all patients; 7 patients 54 were tested with In3diagnostic Eradikit COVID19, the other 17 with EDI™ Novel Coronavirus COVID-19. 55 A total of 3 (12.5%) patients tested positive for both ELISA and chemiluminescence. In 1 patient (4.1%) 56 ELISA test was positive while chemiluminescence was negative. None of the four positive patients 57 presented fever, 50% had cough, and 25% presented transient diarrhea up to 14 days before skin lesion 58 appearance. All 4 patients had contact with a relative who had confirmed SARS-CoV-2 infection (2 59 patients) or anosmia (2 patients). Fecal PCR was tested in 4 patients (16.6%), none was positive; rectal 60 swab was performed in 17 patients (70.8%) and was positive in 1, which also was positive at both 61 serologic tests. 62

Finally, CLL patients were compared with a cohort of 24 SARS-CoV-2 infected children. Table1 shows the 63 comparison between the two groups. Chilblain patients were significantly older (13 vs 4 years old, p < 64 0.0001); fever was present in a limited number of cases (16.7% vs 92%, p < 0.0001), and certainty of 65 exposure to SARS-CoV-2 was limited (8% vs 56%, p < 0.0006). 66 67 According to our data, the hypothesis of a direct aetiological link between SARS-CoV-2 and Chilblain is 68 not confirmed by serological tests; it is difficult to assess if in the four patients with positive serology 69 SARS-CoV-2 was involved in the pathogenesis of CLL or not. A limit of our study is the absence of tissue J o u r n a l P r e -p r o o f

Chilblain-like lesions during COVID-19 epidemic: a 77 preliminary study on 63 patients

Chilblains are a common cutaneous finding during the COVID-80 19 pandemic: a retrospective nationwide study from France

Low prevalence of seroconversion against SARS-CoV-2 in a pediatric cohort of patients with 83

Chilblain-like lesions

COVID-19) infection-induced chilblains: A 86 case report with histopathologic findings

Chilblains in children in the setting of 89

COVID-19 pandemic

Certain Exposore to SARS-COV2

* 22 hospitalized and 3 evaluated in the Emergency Department at the Regina Margherita Children's 102